Veröffentlichungsdatum: 28 Januar 2014
Projektträger – zwischengeschaltetes Finanzinstitut
Development of next generation turbines and rotor blades.
The main project's goals are the reduction of levelized cost of energy (LCoE) by increasing the turbine efficiency as well as reducing total lifetime cost, increase of the turbine's energy yield and full load production hours and product diversification.
The Risk Sharing Finance Facility (RSFF) is an innovative credit risk sharing scheme jointly set up by the European Commission and the European Investment Bank to improve access to debt financing for private companies or public institutions promoting activities with a higher financial risk profile in the fields of research, technological development, demonstration and innovation investments.
- Industrie - Verarbeitendes Gewerbe/Herstellung von Waren
Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)
EUR 90 million
Gesamtkosten (voraussichtlicher Betrag)
EUR 185 million
The R&D activities are expected to be carried out in existing facilities, already authorised, that will not change their scope due to the project. In the light of this the project is not expected to require an Environmental Impact Assessment as per directive 2011/92/EU. However, some of the activities included in the project, notably the development and testing of new WTGs (Wind Turbine Generators), may result in the construction of experimental wind farms and as such could require an EIA and/or have impacts on Nature conservation sites. The Bank's services will investigate the details during the appraisal.
The promoter is a private company not operating in the utilities sector and not having a status of a contracting authority. Thus, it is not covered by the EU directives on procurement.
Unterzeichnet - 28/11/2014
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).